CClinicalTrials.gg
Active, not recruitingNCT07442955Updated Mar 2, 2026

Impact of Digital Muscle Strength on Activity in Tech-Addicted University Students

An observational study in Physical Activities, Muscle Strength and Digital Addiction, sponsored by Ondokuz Mayıs University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by Ondokuz Mayıs University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Results from muscle strength assessment methods commonly used in physiotherapy can vary due to their lack of objective results and their reliance on the individual's muscle strength. Digital muscle testing devices provide objective results because they provide numerical data based on the resistance applied by the individual performing the measurement. These data can objectively identify weakness in specific muscles or muscle groups that may occur due to decreased physical activity levels in university students, and they will also be useful in developing an individualized exercise program.

02

Conditions studied

  • Physical Activities
  • Muscle Strength
  • Digital Addiction

Browse trials for

Keywords

  • Physical Activities
  • Muscle strength
  • Digital addiction
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's planned enrollment of 140 is above the median of 100 across 292 observational studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 262 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Students with Digital Addiction

Inclusion criteria

  • Be between the ages of 18 and 30
  • Be a university student
  • Have no physical or systemic illnesses that would prevent you from working

Exclusion criteria

Exclusion Criteria:

  • Not being between the ages of 18 and 30
  • Not being a university student
  • Having a physical or systemic illness that prevents working
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Groups and cohorts

  • Students with Digital Addiction

    Students with Digital Addiction

    Other: Evaluation of muscle strength

Interventions

  • OtherEvaluation of muscle strength

    Evaluation of muscle strength, Young Internet Addiction Test-Short Form (YIAT-SF), International Physical Activity Questionnaire-Short Form (IPAQ-SF) and SF-12

06

What researchers measure

Primary outcomes

  1. Lafayette Muscle Strength Devices

    The Lafayette muscle strength measurement device is a digital dynamometer used to objectively and numerically assess maximum isometric muscle strength. The device provides a more precise and repeatable measurement than manual muscle testing, providing a reliable method for assessing muscle strength. It can be used with various attachments for different muscle groups and is frequently used in rehabilitation, performance analysis, and clinical research. A high score indicates high muscle strength.

    Time frame: 1 year

  2. International Physical Activity Questionnaire - Short Form (IPAQ-SF)

    The IPAQ-SF is an internationally standardized self-report questionnaire developed to determine individuals' physical activity levels. This seven-question short form assesses \*\*walking, moderate-intensity, and vigorous-intensity physical activities\*\*, as well as \*\*sitting time\*\*, over the past seven days. Using participant-reported duration and frequency data, physical activity level is calculated in \*\*MET-minutes/week\*\*. Its rapid administration and applicability to large populations make it a valid and reliable measurement tool for population-based research and clinical trials. Participants can use physical activity levels of Low, Moderate, or High based on their MET score, depending on the day and time. A higher MET value indicates a higher level of physical activity.

    Time frame: 1 year

Secondary outcomes

  1. Quality of Life (SF-12)

    Quality of Life will assess with SF-12. The SF-12 is a short self-report questionnaire developed to assess individuals' general health status and quality of life. A shortened version of the SF-36, this scale consists of 12 questions and assesses physical and mental health components (Physical Component Summary (PCS) and Mental Component Summary (MCS). Due to its short administration time and practicality, it is frequently used in clinical research, community health studies, and rehabilitation. A high score indicates a high level of life quality. Scores range from 0 to 100. 0 points: Worst health status and 100 points: Best health status. Higher scores indicate better physical or mental health. Lower scores indicate worse health status.

    Time frame: 1 year

07

Study locations

1 site
  • Ondokuz Mayıs University
    Samsun, Turkey (Türkiye)
08

References and documents

Study documents

  • Informed consent form · Apr 1, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07442955
Lead sponsor
Ondokuz Mayıs University
Responsible party
Deniz Çakır (Research Assistant, Ondokuz Mayıs University) — Principal investigator
First posted
Mar 2, 2026
Start date
Feb 1, 2026
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Mar 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion